All Stories

  1. Top-down and bottom-up models for nucleoside reverse transcriptase inhibitors against HIV-1

    Article • European Journal of Pharmaceutical Sciences, October 2016, Elsevier

    Max von Kleist, Mr Sulav Duwal

  2. Systems-pharmacology modelling pipeline for PrEP against HIV-1

    Article • CPT Pharmacometrics & Systems Pharmacology, July 2016, Wiley

    Max von Kleist, Mr Sulav Duwal

  3. Optimal Treatment Strategies in the Context of ‘Treatment for Prevention’ against HIV-1 in Resource-Poor Settings

    Article • PLoS Computational Biology, April 2015, PLOS

    Max von Kleist, Mr Sulav Duwal

  4. Pharmacokinetics and Pharmacodynamics of the Reverse Transcriptase Inhibitor Tenofovir and Prophylactic Efficacy against HIV-1 Infection

    Article • PLoS ONE, July 2012, PLOS

    Max von Kleist, Mr Sulav Duwal